Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.

IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY
Ali Riza Caliskan, Muhsin Murat Muhip Harputluoglu, Emine Samdanci, Salih Cirik, Sezai Yilmaz
{"title":"Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.","authors":"Ali Riza Caliskan,&nbsp;Muhsin Murat Muhip Harputluoglu,&nbsp;Emine Samdanci,&nbsp;Salih Cirik,&nbsp;Sezai Yilmaz","doi":"10.14744/hf.2022.2022.0033","DOIUrl":null,"url":null,"abstract":"<p><p>Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.</p>","PeriodicalId":29722,"journal":{"name":"Hepatology Forum","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/2d/hf-4-074.PMC10209975.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/hf.2022.2022.0033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.

Abstract Image

芬戈莫德致暴发性肝衰竭需要肝移植1例报告。
芬戈莫德用于治疗多发性复发性硬化症已有十年之久。据报道,芬戈莫德引起肝酶升高。在本病例报告中,临床和实验室参数在停药后有所改善。然而,文献中没有关于芬戈莫治疗后急性肝衰竭和肝移植的出版物。在这篇文章中,我们报告了一位33岁的女性患者,她因复发性多发性硬化症接受芬戈莫德治疗后出现急性肝衰竭并接受肝移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
12.50%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信